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In 2007, an expert Working Group convened by the IARC Monographs Programme concluded that shift 
work that involves circadian disruption is probably carcinogenic to humans (Group 2A). We scrutinised 
the epidemiological basis for this conclusion, with a focus on, but not limited to, breast and prostate cancers. 
We further considered practical consequences for shift workers in our industry against the background of 
new ﬁ ndings.
We carried out a literature search including the epidemiological studies cited by IARC and newer available 
literature on shift work and cancer. 
Since the IARC assessment, eleven new studies have emerged, ten of which have already been published, 
with inconclusive results. Heterogeneity of exposure metrics and study outcomes and emphasis on positive 
but non-signiﬁ cant results make it difﬁ cult to draw general conclusions. Also, several reviews and 
commentaries, which have been published meanwhile, came to equivocal results. Published evidence is 
widely seen as suggestive but inconclusive for an adverse association between night work and breast 
cancer, and limited and inconsistent for cancers at other sites and all cancers combined.
At this point in time it can not be ruled out that shift work including night work may increase the risk for 
some cancers in those who perform it. However, shift schedules can be organised in ways that minimise 
the associated health risks, and the risks may be further reduced through the implementation of structured 
and sustained health promotion programs speciﬁ cally tailored to the needs of shift workers.
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Nearly 20 % of the working population in Europe 
and North America works in shifts and because of the 
nature of the production processes involved - the 
chemical industry is particularly dependent on this 
type of work organisation. In 2007, an expert Working 
Group convened by the International Agency for the 
Research on Cancer (IARC) Monographs Programme 
concluded on the basis of “limited evidence in humans 
for the carcinogenicity of shift work that involves night 
work”, and “sufficient evidence in experimental 
animals for the carcinogenicity of light during the 
daily dark period (biological night)” that shift work 
that involves circadian disruption is probably 
carcinogenic to humans (Group 2A) (1). This ruling, 
which was only published as a short “policy watch” 
notice, was soon challenged by other scientists on the 
basis of a systematic review of the relevant literature 
(2). However, an in-depth discussion of the IARC 
assessment has only recently become possible due to 
the fact that the full monograph was only published 
three years after the ﬁ rst communication (3). In this 
article we will shortly summarise the epidemiological 
basis for the IARC assessment and address some 
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inconsistencies, which in our opinion had been given 
too little weight by IARC. We will then summarise 
the new literature on this topic and ﬁ nally, based on 
practical experience from a major chemical company 
in Germany, address the question of consequences for 
the shift work organisation in industry. For the purpose 
of this article, shift work is always considered as work 
involving night work.
THE IARC ASSESSMENT
The IARC ruling was mainly based on two types 
of study populations; first, the published cancer 
experience from nurse cohort members with and 
without shift work, and second, the respective ﬁ ndings 
in ﬂ ight attendants and pilots. In the latter case, long-
haul ﬂ ights across time zones were taken as a proxy 
for shift work, because they were considered to cause 
“circadian disruption”, a concept which IARC sees as 
instrumental for the development of cancer in so 
exposed persons. Noteworthy, on the 200 pages of the 
monograph the term “circadian disruption” occurs 
approximately 40 times, with no deﬁ nition provided. 
For the purpose of the following discussion we may 
tentatively assume that it refers to desynchronisation 
of two or more of the more than hundred known 
physiological processes, which show circadian 
periodicity in humans. However, IARC leaves open 
the question of which ones may be of relevance, and 
to which degree such a disruption would have to occur 
to be of biological signiﬁ cance.
As a matter of fact, most of IARC’s ruling is thus 
based on the reports of female breast cancer. In 
evaluating the evidence in humans, IARC offers a very 
straight-forward approach: six out of eight studies 
(excluding female ﬂ ight attendants) included in the 
review have shown modestly elevated risks, and the 
incidence of breast cancer was also modestly increased 
in most cohorts of female ﬂ ight attendants (1). The 
following Table 1 with the main results from the eight 
studies in “non-aircraft” populations shows that this 
simpliﬁ ed comparison may not represent the full 
picture.
Elevated breast cancer risks appear either after 
having worked in shifts for 30 years (4, 9), or after a 
cumulative exposure to shift work of only six months 
(8). They also appear after having worked in shifts for 
a little more than three years, but only in women aged 
50 years or more (7). Thus, even in this small subset 
of studies there is considerable heterogeneity regarding 
dose metrics and dose-response relations.
IARC scrutinised nine studies on breast cancer in 
aircraft crew (12-20). Most risk estimates from these 
studies are in the range between 1 and 2, but only four 
out of the nine studies reach at least borderline 
statistical significance (12, 14, 16, 18). IARC 
acknowledges the fact that aircraft crew is exposed to 
other possible carcinogenic agents, most notably 
cosmic radiation. Indeed, most of the aircraft crew 
studies were originally targeted at the effects of cosmic 
radiation, estimating cumulative radiation doses as 
exposure of interest. IARC explicitly assumes that the 
number of ﬂ ights across several time zones, which is 
used as a proxy of frequency of circadian rhythm 
disruptions, correlates with the dose of cosmic 
radiation. Therefore, according to IARC, the estimates 
of cancer risk in cumulative radiation dose categories 
could also be interpreted to roughly reflect the 
frequency of circadian rhythm disruptions. This 
assumption, however, disregards that daytime ﬂ ights 
in the north-south direction, thus along one meridian, 
would contribute to the radiation dose but per 
deﬁ nition not lead to “circadian disruption”.
The prostate cancer incidence in aircraft crews has 
been found elevated for pilots, but not for cabin crew, 
in several of the older studies. This excess risk has 
decreased over time and is, according to IARC, 
probably attributable to the use of prostate speciﬁ c 
antigen (PSA) testing, which was common in pilots 
much earlier than in the general population. The two 
largest and most recent studies available in this 
category have found no elevated risks for prostate 
cancer mortality (20, 21). Only two reports on prostate 
cancer risks from other shift-working populations have 
been considered by IARC. In one study, a relative risk 
(RR) of 2.3 based on three cases was seen in persons 
working in fixed night shifts, while a RR of 3.0 
(conﬁ dence interval (CI) 1.2 to 7.7; seven cases) 
resulted for rotating shift workers (22). The other study 
found an odds ratio (OR) of 1.19 (CI 1.0 to 1.42) for 
persons who “normally worked full-time rotating” 
shift, but it did not explain what “normally” meant 
(23). Contrary to IARC’s reading of the paper there 
was no apparent trend with cumulative shift exposure. 
A third study did not enter into this comparison, which 
reported standardised incidence ratios close to unity 
for persons who worked in occupations with >40 % 
shift workers (6).
The evidence found by IARC for other cancers is 
even weaker and will not be discussed in detail in this 
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article. The picture gained so far, however, provokes 
the question whether there was indeed enough 
evidence for the carcinogenicity of shift work at the 
time of the IARC assessment to warrant a classiﬁ cation 
of this link as “probable”. We may also ask whether 
this ruling, if warranted, should apply to all cancers 
or only to female breast cancer.
STUDIES SINCE THE IARC ASSESSMENT
We carried out a PubMed literature search using 
the search term “shift work OR night work OR 
circadian disruption AND cancer” for the period 
between 2007 and the end of 2011. This search yielded 
363 hits, which were then restricted to ten original 
epidemiologic studies in humans; excluding reviews, 
studies targeting exposures that may include but go 
beyond shift work (e.g., light at night), and studies 
examining surrogates for effects (e.g., cancer 
biomarkers) (Table 2). One additional study, which 
was presented at the International EPICOH and 
MEDICHEM Meeting in Taiwan but has not been 
published to date, is further mentioned as personal 
communication.
Since 2007, six new studies have emerged which 
can shed more light on the possible link between shift 
work and female breast cancer. One study in a 
population-based Chinese cohort found a hazard ratio 
(HR) of 1.0 (CI 0.9 to 1.2) for ever working night 
shifts on the basis of a job exposure matrix; the HR 
was 0.9 (CI 0.7 to 1.1) on the basis of self-reported 
history of night shift work (24). In 2010, data from a 
nested case-control study in a different cohort 
consisting of 267,000 Chinese textile workers were 
presented for the ﬁ rst time in Taiwan. The RR for 
Table 1  Heterogeneity in exposure metrics and thresholds in female breast cancer studies (non-aircraft) quoted in the IARC 
assessment; *RR/OR = relative risk or odds ratio, as applicable; CI = conﬁ dence interval
Study type Population Risk estimate(OR/RR; CI)*







1.36 (1.0 to 1.78) ≥30 years





1.79 (1.06 to 3.01) ≥20 years





0.97 (0.67 to 1.40)
occupation with 
>40 % shift workers








0.9 (0.3 to 2.9)
4.3 (0.7 to 26.0)
age <50 and shift work 
>3.1 years
age ≥50 and shift work 
>3.1 years
Tynes et al. 1996 (7)
Case-control
General population, 
7035 cases, one 
matched control per 
case













4 matched controls per 
case
1.3 (0.8 to 2.0)
2.2 (1.1 to 4.5)
15 to 29 years 
≥30 years 
Lie et al. 2006 (9)
Case-control
General population, 
813 cases, 792 age 
matched controls
1.4 (1.0 to 2.0)
ever night shift (at 
least 3 nights per 
week)
Davis et al. 2001 (10)
Case-control
General population, 
576 cases, 585 age 
matched controls
0.55 (0.3 to 0.9)
1.2 (0.9 to 1.6)
any overnight shift
evening shift only
O’Leary et al. 2006 (11)
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Table 2  Studies on shift work and cancer, published after the IARC assessment; *RR/OR/HR = relative risk, odds ratio or hazard 
ratio, as applicable; CI = conﬁ dence interval
Study type and 
cancer of 
interest
Population Risk estimate 
(OR/RR/HR; CI)*








1.0 (0.9 to 1.2)
0.9 (0.7 to 1.1)  
ever night shift (job exposure 
matrix)
ever night shift (self-report)







0.98 (0.74 to 1.29)
1.01 (0.68 to 1.50)
0.91 (0.38 to 2.18)
2.49 (0.87 to 7.18)
ever shift work
ever night work
10 to 19 years night
≥20 years night







1.4 (0.9 to 2.1)
2.4 (0.9 to 6.0)
1.5 (0.9 to 2.6)
employed >10 years as nurse
textile workers
tailors/dressmakers






310 cases, 4 age 
matched controls per 
case
0.9 (0.4 to 1.9)
1.8 (1.2 to 2.8)
2.9 (1.1 to 8.0)
ever evening shift, never 
night
ever after midnight rotating 
shift, never permanent night
ever permanent night in 
addition to rotating night 
shifts









1.1 (0.8 to 1.6)
1.2 (0.8 to 1.7)
1.8 (1.1 to 2.8)
worked ≥5 years with 
≥3 consecutive night shifts
worked <5 years with 
≥6 consecutive night shifts
worked ≥5 years with 
≥6 consecutive night shifts
Lie et al. 2011 (28)
Cohort 
Prostate
4995 male industry 
workers, age 49 to 
65 years (4168 
daytime workers,
827 shift workers, 4 
exposed cases)
1.79 (0.57 to 5.68) three-shift work for >80 % 
of career
Kubo et al. 2011 
(29)
Cohort Prostate General population
(15 million, 339,973 
cases)
All risks for 
occupations with 
shift work around 
unity
Occupation with high 
probability for night work




Nurses, NHS I+II 
(n=181,548), 718 
cases
1.28 (0.84 to 1.94)
0.80 (0.51 to 1.23)
15 to 19 years rotating night 
shift
≥20 years rotating night shift







0.80 (0.51 to 1.23)
skin cancer
0.56 (0.36 to 0.87)
melanoma








1.10 (1.03 to 1.19) Occupation with high 
probability for night work
Lahti et al. 2008 
(33)
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having worked shifts for 1 to <10 years, 10 to <20 
years, and 20+ years compared with less than 1 year 
were 0.99, 1.0, and 0.92, respectively (W. Li, personal 
communication). In a re-analysis of case-control data 
originally gathered for a different set of risk factors, 
shift work (ever vs. never) had an OR for female breast 
cancer of 0.98 (CI 0.74 to 1.29); night work (ever vs. 
never) was associated with an OR of 1.01 (CI 0.68 to 
1.50); there were non-significantly reduced risk 
estimates for exposure metrics below the median, and 
non-signiﬁ cantly increased risks above the median. 
The OR was 2.49 (CI 0.87 to 7.18) for more than 20 
years of night shift work, while all other risk estimates 
were below unity (25). Surprisingly, the authors of 
this study concluded that their ﬁ ndings were “in line 
with the IARC classiﬁ cation.” In a French case-control 
study on occupation as a risk factor for breast cancer, 
an OR of 1.4 (CI 0.9 to 2.1) emerged for women 
employed for more than 10 years as nurses. An overall 
OR of 2.4 (CI 0.9 to 6.0) was reported in textile 
workers and 1.5 (CI 0.9 to 2.6) in tailors/dressmakers, 
with no information available on working time 
schedules of these occupational groups (26). In a 
nested case-control study from a cohort of Danish 
nurses, signiﬁ cantly increased ORs ranging between 
1.8 and 2.9 were found when work after midnight was 
compared with permanent day work (27). There was 
no apparent effect of evening work, if night work was 
excluded. An interesting new aspect was added by the 
re-analysis of data from a Norwegian case-control 
study (9, 28). Here, a signiﬁ cantly increased OR of 
1.8 (CI 1.1 to 2.8) was seen in nurses who worked ≥5 
years with ≥6 consecutive night shifts. 
Two new studies have emerged regarding prostate 
cancer. An OR of 1.79 (CI 0.57 to 5.68), based on only 
four exposed cases, was seen in persons who had 
performed three-shift work for >80 % of their career, 
if compared to persons who had never worked shifts 
(29). On the other hand, no indication of an association 
with occupation was seen among 339,973 prostate 
cancer cases in a cohort of 15 million people aged 30 
to 64 years in the 1960, 1970, 1980/1981 and/or 1990 
censuses in Denmark, Finland, Iceland, Norway and 
Sweden (30). 
Little new information has emerged for other 
cancer types. In one study, the HR for ovarian cancer 
was 1.28 (CI 0.84 to 1.94) in women who performed 
15 to 19 years of rotating night shifts, and 0.80 (CI 
0.51 to 1.23) for those with more than 20 years of shift 
work (31). A 14 % decreased risk of skin cancer, and 
44 % decreased risk of melanoma, was seen after more 
than 10 years of rotating night shifts (32). The RR for 
non-Hodgkin’s lymphoma was 1.10 (CI 1.03 to 1.19) 
for men who worked night shifts, and it increased to 
1.28 (CI 1.03 to 1.59) when a lag period of 10 years 
was applied (33).
CONSEQUENCES FOR SHIFT WORKERS 
IN INDUSTRY - EXPERIENCE FROM A 
LARGE CHEMICAL COMPANY
While we agree with the conclusion drawn by 
Wang et al. (34) in their in-depth review that 
“heterogeneity of study exposures and outcomes and 
emphasis on positive but non-signiﬁ cant results make 
it difﬁ cult to draw general conclusions” from the 
existing literature on shift work and cancer, this lack 
of evidence should not lead to complacency in the 
persons who are responsible for workers’ health. 
Recommendations for measures to counteract expected 
negative effects of night work are more often 
“eminence-based” than “evidence-based” (35). These 
recommendations include a selection of “shift tolerant” 
individuals, favouring of forward rotating shift 
schedules (morning - afternoon - night) over backward 
rotation (night - afternoon - day), avoidance of 
multiple night-shifts in a row, interventions through 
bright light or medication, physical exercise, and 
others.
Given that shift work is simply unavoidable in 
many occupations and industries, it is the duty of 
occupational physicians and scientists to examine the 
potential risks associated with this kind of work 
organisation. Health risks, if any, have to be minimised 
as far as possible and, where they can not be avoided, 
means of intervention and - if necessary - compensation 
have to be discussed. To this end we performed studies 
in more than 17.000 shift and 13.000 day workers at 
a major chemical site in Germany. We compared the 
acute and chronic illness experience, the accident 
rates, and the overall mortality across these groups of 
workers with the surprising result of generally more 
favourable outcomes for shift workers, after adjusting 
for smoking habits and other known relevant 
confounders (36, 37). Even the overall cancer 
incidence was reduced in shifts if compared to day 
workers. It has to be emphasised, however, that owing 
to German data protection legislation our database is 
weak regarding cancer incidence, and our conclusions 
regarding the question of carcinogenicity of shift work 
in our workforce are preliminary. There are several 
Yong M, Nasterlack M. SHIFT WORK AND CANCER
Arh Hig Rada Toksikol 2012;63:153-160
158
possible explanations for the unexpected lack of 
adverse health effects of shift work in this study 
population. First, the shift system in place never 
requires more than one night shift in a row. Second, 
it is forward rotating, with night work always followed 
by a resting period of 24 (old system) or 48 hours (new 
system). With regard to the IARC concept of “circadian 
disruption”, we hypothesise that desynchronisation of 
circadian biological rhythms does not occur to a 
sizable degree under these circumstances. This 
assumption can further be supported by the observation 
that workers in both shift systems did not complain 
about subjective health impairment more than day 
workers with the same socio-economic background 
(38). Whether health promotion programs for workers 
result in long-term health beneﬁ ts is equivocal (39, 
40), but it may reasonably be assumed provided such 
programs are not only offered on a one-time basis. We 
were indeed able to demonstrate that shift workers in 
our studied populations were more often participating 
in such programs than day workers, and participation 
in health promotion activities was associated with 
reduced overall mortality, if compared to non-
participation (41). However this reduced mortality 
was not apparently triggered by reduced cancer 
incidence in participants (RR 1.07; CI 0.84 to 1.36). 
CONCLUSION
Based on the literature available, it can not be 
conﬁ dently ruled out that shift work including night 
work may, possibly depending on the way how it is 
organised, increase the risk for some cancers in those 
who perform it. However, at this point in time there 
is no reason to believe that shift-workers in general 
face an increased cancer risk. In any case, shift 
schedules can probably be organised in ways that 
minimise the associated health risks, and the risks may 
be further reduced through the implementation of 
structured and sustained health promotion programs 
speciﬁ cally tailored to the needs of shift workers. The 
recommendation to use fast forward rotating shift 
schedules with no more than one or two subsequent 
night shifts can be supported on the basis of our 
experience.
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Sažetak 
RAD U SMJENAMA I RAK - ZNANSTVENE SPOZNAJE I PRAKTIČNE POSLJEDICE
Stručna radna skupina, koju je okupio Program monograﬁ ja Međunarodne agencije za istraživanje raka 
(eng. International Agency for Research on Cancer, krat. IARC), 2007. godine zaključila je da je rad u 
smjenama, koji uključuje prekid cirkadijurnoga ritma, najvjerojatnije kancerogen za ljude (skupina 2A). 
Procijenili smo epidemiološku osnovu takvoga zaključka i usredotočili se na rak dojke i rak prostate između 
ostalih malignih bolesti. Nadalje, razmatrali smo praktične posljedice koje rad u smjenama ima na radnike 
u kemijskoj kompaniji BASF u okvirima novih spoznaja na tom području.
Istražili smo literaturu, uključujući i epidemiološka istraživanja studije koje citira IARC kao i noviju 
literaturu o povezanosti rada u smjenama i raku.
Od zaključka IARC-a nastalo je jedanaest novih istraživanja, a deset ih je već objavljeno. Njihovi rezultati 
ipak ne dovode do konačnoga i jednoznačnoga zaključka. Heterogenost mjerenja izloženosti i ishoda 
istraživanja i naglasak na pozitivne, ali ne uvijek i značajne rezultate, otežavaju postavljanje općih 
zaključaka. Jednako tako u nekoliko nedavno objavljenih recenzija i komentara ne iznose se jednoznačni 
rezultati. Objavljeni znanstveno utemeljeni dokazi samo upućuju, ali ne dovode u očiglednu vezu noćni 
rad i rak dojke. Nadalje, ograničeni su i nedosljedni za malignome na drugim lokacijama u tijelu, kao i za 
sve malignome zajedno.
U ovom trenutku nije moguće odbaciti hipotezu da smjenski rad (uključujući noćni rad) može povećati 
rizik nastanka određenih malignih bolesti. Međutim, raspored smjena se može organizirati na način da se 
opasnosti za zdravlje svedu na najmanju moguću mjeru. Rizici se također mogu dodatno smanjiti provedbom 
strukturiranih programa promicanja održivoga zdravlja koji bi bili posebno osmišljeni prema potrebama 
radnika.
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